Sex Differences in Age of Diagnosis, HLA Genotype, and Autoantibody Profile in Children With Type 1 Diabetes

Diabetes Care. 2023 Nov 1;46(11):1993-1996. doi: 10.2337/dc23-0124.

Abstract

Objective: To examine sex differences in children with newly diagnosed type 1 diabetes (T1D) with respect to age at diagnosis, presence of autoantibodies (GAD antibody [GADA], insulinoma-associated protein 2 [IA-2A], insulin autoantibody [IAA], and zinc transporter 8 autoantibody), and HLA risk.

Research design and methods: A population-based nationwide sample of 3,645 Swedish children at T1D diagnosis was used.

Results: Girls were younger at T1D diagnosis (9.53 vs. 10.23 years; P < 0.001), more likely to be autoantibody-positive (94.7% vs. 92.0%; P = 0.002), more often positive for multiple autoantibodies (P < 0.001), more likely to be positive for GADA (64.9% vs. 49.0%; P < 0.001), and less likely to be positive for IAA (32.3% vs. 33.8%; P = 0.016). Small sex differences in HLA risk were found in children <9 years of age.

Conclusions: The disease mechanisms leading to T1D may influence the immune system differently in girls and boys.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Autoantibodies
  • Child
  • Diabetes Mellitus, Type 1* / diagnosis
  • Female
  • Genotype
  • Glutamate Decarboxylase
  • HLA-DQ Antigens / genetics
  • Humans
  • Insulin Antibodies
  • Male
  • Sex Characteristics

Substances

  • Autoantibodies
  • HLA-DQ Antigens
  • Insulin Antibodies
  • Glutamate Decarboxylase